Skip to Content

Tag: Biolinq


Also Noted

Biosensor tech company secures $100M investment

April 22, 2025HME News Staff

SAN DIEGO – Biolinq, a healthcare technology company of biosensors, has received a $100 million Series C financing led by Alpha Wave Ventures, with participation from existing investors RiverVest Venture Partners, AXA IM Alts, LifeSci Venture Partners, M Ventures, Hikma Ventures, Aphelion Capital, Taisho Pharmaceutical and Features Capital. The funding will support Biolinq through the US regulatory approval process as the company prepares to bring the first autonomous intradermal glucose sensor...

Biolinq, biosensor, Glucose monitoring, wearables


Read Full Articlered right arrow icon